These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1575742)

  • 1. Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions.
    Orlando R; Kenny PT; Zagorski MG
    Biochem Biophys Res Commun; 1992 Apr; 184(2):686-91. PubMed ID: 1575742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
    Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
    J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acid.
    Klunk WE; Pettegrew JW
    J Neurochem; 1990 Jun; 54(6):2050-6. PubMed ID: 2187054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR identification of the formic acid-modified residue in Alzheimer's amyloid protein.
    Klunk WE; Xu CJ; Pettegrew JW
    J Neurochem; 1994 Jan; 62(1):349-54. PubMed ID: 8263535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
    Shao H; Jao S; Ma K; Zagorski MG
    J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.
    Miller DL; Papayannopoulos IA; Styles J; Bobin SA; Lin YY; Biemann K; Iqbal K
    Arch Biochem Biophys; 1993 Feb; 301(1):41-52. PubMed ID: 8442665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formylated peptides from cyanogen bromide digests identified by fast atom bombardment mass spectrometry.
    Goodlett DR; Armstrong FB; Creech RJ; van Breemen RB
    Anal Biochem; 1990 Apr; 186(1):116-20. PubMed ID: 2356963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of aggregation of synthetic beta-amyloid peptide.
    Tomski SJ; Murphy RM
    Arch Biochem Biophys; 1992 May; 294(2):630-8. PubMed ID: 1567217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Interconversion in Alzheimer's Amyloid-β(16-35) Peptide in an Aqueous Solution.
    Alves NA; Frigori RB
    J Phys Chem B; 2018 Feb; 122(6):1869-1875. PubMed ID: 29351720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some neurochemical applications of electrospray ionization-mass spectrometry.
    Oliver RW; Green BN
    Biochem Soc Trans; 1994 Feb; 22(1):131-5. PubMed ID: 8206208
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the aggregation propensity of the β -amyloid peptide during the synthesis and when free in solution.
    Malavolta L; Pinto MR; Nakaie CR
    Protein Pept Lett; 2013 Aug; 20(8):848-55. PubMed ID: 23458076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide.
    Döbeli H; Draeger N; Huber G; Jakob P; Schmidt D; Seilheimer B; Stüber D; Wipf B; Zulauf M
    Biotechnology (N Y); 1995 Sep; 13(9):988-93. PubMed ID: 9636276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.
    Snyder SW; Ladror US; Wade WS; Wang GT; Barrett LW; Matayoshi ED; Huffaker HJ; Krafft GA; Holzman TF
    Biophys J; 1994 Sep; 67(3):1216-28. PubMed ID: 7811936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ab initio model studies of copper binding to peptides containing a His-His sequence: relevance to the beta-amyloid peptide of Alzheimer's disease.
    Raffa DF; Gómez-Balderas R; Brunelle P; Rickard GA; Rauk A
    J Biol Inorg Chem; 2005 Dec; 10(8):887-902. PubMed ID: 16267663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    Eur J Biochem; 1991 Oct; 201(1):61-9. PubMed ID: 1915378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.
    Shen CL; Fitzgerald MC; Murphy RM
    Biophys J; 1994 Sep; 67(3):1238-46. PubMed ID: 7811938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal ion mediated transition from random coil to β-sheet and aggregation of Bri2-23, a natural inhibitor of Aβ aggregation.
    Luczkowski M; De Ricco R; Stachura M; Potocki S; Hemmingsen L; Valensin D
    Metallomics; 2015 Mar; 7(3):478-90. PubMed ID: 25633876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An infrared spectroscopy approach to follow β-sheet formation in peptide amyloid assemblies.
    Seo J; Hoffmann W; Warnke S; Huang X; Gewinner S; Schöllkopf W; Bowers MT; von Helden G; Pagel K
    Nat Chem; 2017 Jan; 9(1):39-44. PubMed ID: 27995915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.